Samples | Conc. (μ g/mL) | DPPH Percent inhibition | DPPH IC 50 (μ g/mL) | ABTS Percent inhibition | ABTS IC 50 (μ g/mL) |
---|---|---|---|---|---|
Al.MeF | 1000 | 83.23 ± 0.44** | 82 | 81.49 ± 0.60*** | 70 |
500 | 79.50 ± 0.61 ns | 75.45 ± 0.59** | |||
250 | 68.47 ± 0.46*** | 64.52 ± 0.60*** | |||
125 | 53.47 ± 0.70*** | 57.58 ± 0.57*** | |||
Al.HxF | 1000 | 65.57 ± 0.43*** | 270 | 69.90 ± 1.04 *** | 215 |
500 | 58.12 ± 0.94*** | 61.53 ± 0.65*** | |||
250 | 48.76 ± 1.09*** | 52.20 ± 1.04*** | |||
125 | 34.38 ± 0.50*** | 40.50 ± 0.73*** | |||
Al.CfF | 1000 | 74.50 ± 0.56*** | 210 | 83.42 ± 0.57*** | 190 |
500 | 61.40 ± 0.55*** | 72.32 ± 0.52*** | |||
250 | 52.36 ± 0.57*** | 58.27 ± 0.57*** | |||
125 | 43.30 ± 0.52*** | 37.30 ± 0.64*** | |||
Al.EaF | 1000 | 69.37 ± 0.58*** | 382 | 76.34 ± 0.63*** | 360 |
500 | 62.29 ± 0.43*** | 67.54 ± 0.46*** | |||
250 | 24.58 ± 0.56*** | 33.48 ± 0.60*** | |||
125 | 17.39 ± 0.60*** | 28.52 ± 0.66*** | |||
Al.WtF | 1000 | 67.83 ± 1.07*** | 210 | 69.37 ± 1.10*** | 310 |
500 | 61.56 ± 0.69*** | 57.56 ± 0.45*** | |||
250 | 52.48 ± 0.54*** | 46.36 ± 0.55*** | |||
125 | 40.90 ± 1.16*** | 35.57 ± 0.84*** | |||
Al.SPF | 1000 | 83.37 ± 0.52** | 83 | 78.40 ± 0.51*** | 92 |
500 | 73.38 ± 0.76*** | 71.44 ± 0.55*** | |||
250 | 67.24 ± 0.80*** | 63.47 ± 0.52*** | |||
125 | 54.40 ± 0.76*** | 52.39 ± 0.49*** | |||
Al.FLVF | 1000 | 89.41 ± 0.55 ns | 33 | 90.34 ± 0.55 ns | 30 |
500 | 83.27 ± 0.58 ns | 86.36 ± 0.49*** | |||
250 | 76.35 ± 0.51 ns | 73.52 ± 0.62 ns | |||
125 | 63.28 ± 0.57 * | 67.42 ± 0.55 ns | |||
Ascorbic Acid | 1000 | 87.90 ± 0.96 | 14 | 89.30 ± 0.61 | 37 |
500 | 83.08 ± 0.47 | 80.37 ± 0.54 | |||
250 | 79.85 ± 2.24 | 73.37 ± 0.64 | |||
125 | 67.36 ± 0.57 | 64.45 ± 0.65 |